Linda A Fitzpatrick Sutro Biopharma, Inc. (STRO) insider trading activity

Linda A Fitzpatrick is CHIEF PEOPLE & COMM. OFFICER of SUTRO BIOPHARMA, INC.. Currently has a direct ownership of 95,433 shares of STRO, which is worth approximately $70,620. The most recent transaction as insider was on Mar 05, 2025, when has been sold 3,594 shares (Common Stock) at a price of $1.36 per share, resulting in proceeds of $4,887. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 95.4K

30.82% 3M change

30.82% 12M change

Total Value Held $70,620

LINDA A FITZPATRICK Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 05 2025	SELL Payment of exercise price or tax liability	$4,887 $1.36 p/Share	3,594 Reduced 3.63%	95,433 Common Stock
Mar 05 2025	BUY Exercise of conversion of derivative security	-	8,750 Added 8.12%	99,027 Common Stock
Mar 04 2025	SELL Payment of exercise price or tax liability	$5,322 $1.42 p/Share	3,748 Reduced 3.99%	90,277 Common Stock
Mar 04 2025	BUY Exercise of conversion of derivative security	-	9,125 Added 8.85%	94,025 Common Stock
Mar 01 2025	SELL Payment of exercise price or tax liability	$13,239 $1.59 p/Share	8,327 Reduced 8.93%	84,900 Common Stock
Mar 01 2025	BUY Exercise of conversion of derivative security	-	20,275 Added 17.86%	93,227 Common Stock
Mar 05 2024	SELL Payment of exercise price or tax liability	$14,110 $4.54 p/Share	3,108 Reduced 4.09%	72,952 Common Stock
Mar 05 2024	BUY Exercise of conversion of derivative security	-	8,750 Added 10.32%	76,060 Common Stock
Mar 04 2024	SELL Payment of exercise price or tax liability	$17,909 $4.79 p/Share	3,739 Reduced 5.26%	67,310 Common Stock
Mar 04 2024	BUY Exercise of conversion of derivative security	-	9,125 Added 11.38%	71,049 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$12,429 $4.95 p/Share	2,511 Reduced 3.9%	61,924 Common Stock
Mar 01 2024	BUY Exercise of conversion of derivative security	-	6,875 Added 9.64%	64,435 Common Stock
Jan 29 2024	SELL Payment of exercise price or tax liability	$16,866 $4.99 p/Share	3,380 Reduced 5.55%	57,560 Common Stock
Jan 29 2024	BUY Exercise of conversion of derivative security	-	8,250 Added 11.92%	60,940 Common Stock
Jan 27 2023	SELL Payment of exercise price or tax liability	$25,230 $7.5 p/Share	3,364 Reduced 7.55%	41,210 Common Stock
Jan 27 2023	BUY Exercise of conversion of derivative security	-	8,250 Added 15.62%	44,574 Common Stock
Mar 05 2022	SELL Payment of exercise price or tax liability	$24,281 $8.17 p/Share	2,972 Reduced 7.56%	36,324 Common Stock
Mar 05 2022	BUY Exercise of conversion of derivative security	-	8,750 Added 18.21%	39,296 Common Stock
Jan 29 2022	SELL Payment of exercise price or tax liability	$35,118 $10.39 p/Share	3,380 Reduced 9.96%	30,546 Common Stock
Jan 29 2022	BUY Exercise of conversion of derivative security	-	8,250 Added 19.56%	33,926 Common Stock
Sep 24 2021	SELL Payment of exercise price or tax liability	$50,363 $19.23 p/Share	2,619 Reduced 9.26%	25,676 Common Stock
Sep 24 2021	BUY Exercise of conversion of derivative security	-	7,576 Added 21.12%	28,295 Common Stock
Jan 29 2021	SELL Payment of exercise price or tax liability	$69,706 $22.15 p/Share	3,147 Reduced 13.19%	20,719 Common Stock
Jan 29 2021	BUY Exercise of conversion of derivative security	-	8,250 Added 25.69%	23,866 Common Stock
Jan 19 2021	BUY Exercise of conversion of derivative security	$7,203 $4.36 p/Share	1,652 Added 9.57%	15,616 Common Stock

LAF

Linda A Fitzpatrick

CHIEF PEOPLE & COMM. OFFICER

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells STRO shares.

Notify only if

Value

Insider Trading

Get notified when an Sutro Biopharma, Inc. insider buys or sells STRO shares.

Notify only if

Operation

Value

Type

News

Receive news related to SUTRO BIOPHARMA, INC.

Track Activities on STRO

Account